Trial Profile
A Phase 1 Study Evaluating The Pharmacokinetics And Pharmacodynamics Of Rn316 In Combination With Atorvastatin In Hypercholesterolemic Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Bococizumab (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 07 Nov 2012 Pooled analysis presented at the 85th Annual Scientific Sessions of the American Heart Association.
- 17 Jun 2011 Actual end date (April 2011) added as reported by ClinicalTrials.gov.
- 17 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.